Metraipolis › archive › dc_77dcdff77769

Efficacy of an intranasally administered live attenuated PRRSV-2 vaccine against challenge with a highly virulent PRRSV-1 strain — Europe PMC PMID:40919027

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40919027
DOI: 10.3389/fvets.2025.1619052
License (as archived): solo-consultazione
Archived: 2026-11-10T10:59:04.551Z
SHA-256 of the archived text: a5fd5d7d42d26b2241538632ff6cb2a6f35b146a610aed862bfbcf1779945314
Stable URL of this page: https://metraipolis.com/documento/dc_77dcdff77769

How to cite

Efficacy of an intranasally administered live attenuated PRRSV-2 vaccine against challenge with a highly virulent PRRSV-1 strain — Europe PMC PMID:40919027 — Europe PMC (en), https://europepmc.org/article/MED/40919027 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_77dcdff77769 (Metraipolis archive dc_77dcdff77769, sha256 a5fd5d7d42d26b2241538632ff6cb2a6f35b146a610aed862bfbcf1779945314)

BibTeX

@misc{dc77dcdff77769,
  title = {Efficacy of an intranasally administered live attenuated PRRSV-2 vaccine against challenge with a highly virulent PRRSV-1 strain — Europe PMC PMID:40919027},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40919027},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_77dcdff77769; sha256 a5fd5d7d42d26b2241538632ff6cb2a6f35b146a610aed862bfbcf1779945314},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40919027. Agents can read the archived copy with the MCP tool read_document.